Company

A scientific supply chain with a mind — powered by KuAI Biotech

Allabio is a next-generation life science platform incubated and wholly held by KuAI Biotech.
It is built not merely to sell reagents, but to reshape how discovery is supported—from hypothesis to data, from bench to decision.


Who We Are

Allabio is a fast growing supply chain platform serving academic laboratories, translational research institutes, biotech startups, and industrial R&D teams across Europe and globally.

Rooted in KuAI Biotech’s strength in AI-for-Science, Allabio translates deep computational insight into practical experimental infrastructure.


What We Do

Allabio integrates high-quality reagents, analytical technologies, and intelligent services into a coherent platform, with four strategic pillars:

1. Protein & Interaction Analysis

From antibodies to functional validation:

  • Antibody reagents & detection solutions
  • TR-FRET–based homogeneous assays for binding, screening, and kinetics
  • Protein–ligand and protein–protein interaction workflows
    Designed for speed, robustness, and industrial reproducibility.

2. Gene & Molecular Analysis

Precision begins at the nucleotide level:

  • ddPCR solutions for absolute quantification
  • Advanced mFISH for spatial genomics
  • Gene expression and copy-number analysis pipelines
    Supporting oncology, rare disease, and gene therapy research.

3. Cell, Organoid & Advanced Models

Closer to biology, further from artifacts:

  • Defined hydrogels and ECM-mimetic systems
  • Tumor and tissue organoid culture solutions
  • Single-cell preparation and functional assays
    Built for precision medicine, not generic cell growth.

4. AI-for-Science Solution

This is where Allabio diverges from traditional distributors:

  • AI and Quantum computing based ligand binding and molecular dynamic prediction
  • AI modeling for multiomics tranlational research
  • Integration of in silico insight with in vitro validation

Our Vision

Allabio is designed as a long-term scientific infrastructure, not a short-term catalogue business.

We envision a platform where:

  • Products, data, and computation speak the same language
  • Experimental failure is anticipated, not discovered late
  • European research ecosystems gain strategic autonomy in tools and insight

Quietly ambitious. Technically grounded. Unapologetically forward-looking.

KUAI biotech. 2025